Jordan E. Pomeroy, Ph.D. - Publications
Affiliations: | 2012 | Systems Biology and Disease | University of Southern California, Los Angeles, CA, United States |
Area:
Human Development, Medicine and Surgery, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2017 | Pomeroy JE, Nguyen HX, Hoffman BD, Bursac N. Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells. Theranostics. 7: 3539-3558. PMID 28912894 DOI: 10.7150/Thno.20593 | 0.639 | |||
2016 | Pomeroy JE, Hough SR, Davidson KC, Quaas AM, Rees JA, Pera MF. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts. Stem Cells Translational Medicine. PMID 27160704 DOI: 10.5966/Sctm.2015-0250 | 0.669 | |||
2011 | Quaas A, Pomeroy J, Paulson R, Pera M. Elucidating mechanisms of reprogramming in induced pluripotent stem cells (iPSCs): immunohistochemical analysis of key factors Fertility and Sterility. 96: S103. DOI: 10.1016/J.Fertnstert.2011.07.405 | 0.652 | |||
2011 | Quaas A, Pomeroy J, Huang G, Paulson R, Pera M. Early Markers of Reprogramming in Induced Pluripotent Stem Cells (iPSCs): A Timeline of Key Steps in the Reprogramming Process Fertility and Sterility. 95: S5. DOI: 10.1016/J.Fertnstert.2011.01.045 | 0.657 | |||
2010 | Hasegawa K, Zhang P, Wei Z, Pomeroy JE, Lu W, Pera MF. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion. Stem Cells (Dayton, Ohio). 28: 1338-48. PMID 20572011 DOI: 10.1002/Stem.466 | 0.643 | |||
2010 | Hasegawa K, Pomeroy JE, Pera MF. Current technology for the derivation of pluripotent stem cell lines from human embryos. Cell Stem Cell. 6: 521-31. PMID 20569689 DOI: 10.1016/J.Stem.2010.05.010 | 0.652 | |||
Show low-probability matches. |